Evidence map›Paper›PMID 29305699›Full record

ArticleApplied microbiology and biotechnology2018

Forward genetics screen coupled with whole-genome resequencing identifies novel gene targets for improving heterologous enzyme production in Aspergillus niger.

Morgann C Reilly, Joonhoon Kim, Jed Lynn, Blake A Simmons, John M Gladden, Jon K Magnuson, Scott E Baker

Open access · hybridAbstract read
In one paragraph

Article in Applied microbiology and biotechnology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Phenotype to genotype inCurrent research in microbial sciences · 2022
    Article
  5. Review
  6. Article
  7. Protein hyperproduction in fungi by design.Applied microbiology and biotechnology · 2018
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Morgann C ReillyJoint BioEnergy Institute, Emeryville, CA, 94608, USA.
Joonhoon KimJoint BioEnergy Institute, Emeryville, CA, 94608, USA.
Jed LynnJoint BioEnergy Institute, Emeryville, CA, 94608, USA.
Blake A SimmonsJoint BioEnergy Institute, Emeryville, CA, 94608, USA.
John M GladdenJoint BioEnergy Institute, Emeryville, CA, 94608, USA.
Jon K MagnusonJoint BioEnergy Institute, Emeryville, CA, 94608, USA.
Scott E BakerJoint BioEnergy Institute, Emeryville, CA, 94608, USA. scott.baker@pnnl.gov.ORCID http://orcid.org/0000-0001-5085-3106
Pacific Northwest National Laboratory · USEnvironmental Molecular Sciences Laboratory · USLawrence Berkeley National Laboratory · USSandia National Laboratories California · USWright-Patterson Air Force Base · US

Funding

Biological and Environmental Research DE-AC02-05CH11231
6 · The paper itself

Abstract

Plant biomass, once reduced to its composite sugars, can be converted to fuel substitutes. One means of overcoming the recalcitrance of lignocellulose is pretreatment followed by enzymatic hydrolysis. However, currently available commercial enzyme cocktails are inhibited in the presence of residual pretreatment chemicals. Recent studies have identified a number of cellulolytic enzymes from bacteria that are tolerant to pretreatment chemicals such as ionic liquids. The challenge now is generation of these enzymes in copious amounts, an arena where fungal organisms such as Aspergillus niger have proven efficient. Fungal host strains still need to be engineered to increase production titers of heterologous protein over native enzymes, which has been a difficult task. Here, we developed a forward genetics screen coupled with whole-genome resequencing to identify specific lesions responsible for a protein hyper-production phenotype in A. niger. This strategy successfully identified novel targets, including a low-affinity glucose transporter, MstC, whose deletion significantly improved secretion of recombinant proteins driven by a glucoamylase promoter.

Indexed as

Gene ExpressionAspergillus nigerEnzymesGenetic TestingMutagenesisMutationRecombinant ProteinsWhole Genome SequencingEnzymesRecombinant ProteinsAspergillus nigerForward mutagenesisHeterologous protein expressionMstCWhole-genome resequencing

Identifiers

PMID29305699
PMCPMC5794824
OpenAlexW2781490399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.